Jeonjinbio Co., Ltd. (KOSDAQ:110020)
South Korea · Delayed Price · Currency is KRW 2,260.00
+35.00 (1.57%)
At close: Apr 1, 2026
Jeonjinbio Revenue
In the year 2025, Jeonjinbio had annual revenue of 13.69B KRW, down -28.94%. Jeonjinbio had revenue of 3.44B in the quarter ending December 31, 2025, a decrease of -21.81%.
Revenue
13.69B
Revenue Growth
-28.94%
P/S Ratio
1.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
20.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.69B | -5.58B | -28.94% |
| Dec 31, 2024 | 19.27B | 3.59B | 22.91% |
| Dec 31, 2023 | 15.68B | 7.89B | 101.18% |
| Dec 31, 2022 | 7.79B | 4.58B | 142.48% |
| Dec 31, 2021 | 3.21B | -652.23M | -16.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| I-Scream Edu | 95.15B |
| NextEye | 78.67B |
| Inter-M | 60.33B |
| PAKERS.Co.,Ltd. | 53.50B |
| Bonne | 50.94B |
| VC Inc. | 46.90B |
| EMnI Co., Ltd. | 31.24B |
| Ubion Co.Ltd. | 30.72B |